Latest News for: stk

Edit

Stoke Therapeutics Announces Presentations of STK-002, an Investigational Medicine for the Treatment of Autosomal Dominant ...

Business Wire 06 Oct 2026
STK-002 is an investigational medicine designed to target the underlying cause of Autosomal ...
  • 1
×